OBJECTIVE: Saliva is a biofluid that can be obtained from individuals without supervision by health care providers. To maximize this clinical advantage, it is highly desirable to have a global salivary analyte stabilizer for proteins, RNA and DNA at ambient temperature. DESIGN: Whole saliva, saliva supernatant and saliva filtrate (5.0 microm) were treated with RPS at room temperature (RT) for up to 6 days and then subjected to SDS-PAGE. Immunoblotting of beta-actin and cystatin C were used to evaluate protein stability. For salivary DNA/RNA, whole saliva was incubated with RPS at RT for up to 10 weeks. After extracting total DNA/RNA in samples at week 0, 2, 6 and 10, DNA stability was assayed by chromosome 18 DNA qPCR and RNA stability by beta-actin mRNA RT-qPCR. RESULTS: beta-actin completely degraded in all types of saliva samples after 6-day incubation at RT. However, 24.0%, 91.4% and 89.3% of beta-actin remained intact with RPS for whole saliva, saliva supernatant and filtrate, respectively. Similarly, 70.3% of cystatin C in supernatant remained intact in the presence of RPS. For salivary DNA/RNA, the cycle threshold (Ct) values showed no significant change for chromosome 18 DNA and beta-actin mRNA in RPS-incubated saliva during the 10-week time course while significant increase in Ct values were observed in controls without RPS for both beta-actin mRNA and DNA. CONCLUSIONS: RPS provided effective concurrent stabilization to salivary DNA/RNA in whole saliva for up to 10 weeks and proteins in saliva filtrate for 6 days at RT. We also achieved separation of saliva supernatant from cellular elements by a simple filtration step (bypassing the need for centrifugation).
OBJECTIVE: Saliva is a biofluid that can be obtained from individuals without supervision by health care providers. To maximize this clinical advantage, it is highly desirable to have a global salivary analyte stabilizer for proteins, RNA and DNA at ambient temperature. DESIGN: Whole saliva, saliva supernatant and saliva filtrate (5.0 microm) were treated with RPS at room temperature (RT) for up to 6 days and then subjected to SDS-PAGE. Immunoblotting of beta-actin and cystatin C were used to evaluate protein stability. For salivary DNA/RNA, whole saliva was incubated with RPS at RT for up to 10 weeks. After extracting total DNA/RNA in samples at week 0, 2, 6 and 10, DNA stability was assayed by chromosome 18 DNA qPCR and RNA stability by beta-actin mRNA RT-qPCR. RESULTS:beta-actin completely degraded in all types of saliva samples after 6-day incubation at RT. However, 24.0%, 91.4% and 89.3% of beta-actin remained intact with RPS for whole saliva, saliva supernatant and filtrate, respectively. Similarly, 70.3% of cystatin C in supernatant remained intact in the presence of RPS. For salivary DNA/RNA, the cycle threshold (Ct) values showed no significant change for chromosome 18 DNA and beta-actin mRNA in RPS-incubated saliva during the 10-week time course while significant increase in Ct values were observed in controls without RPS for both beta-actin mRNA and DNA. CONCLUSIONS: RPS provided effective concurrent stabilization to salivary DNA/RNA in whole saliva for up to 10 weeks and proteins in saliva filtrate for 6 days at RT. We also achieved separation of saliva supernatant from cellular elements by a simple filtration step (bypassing the need for centrifugation).
Authors: Noh Jin Park; Tianwei Yu; Vishad Nabili; Brigitta M N Brinkman; Sharon Henry; Jianghua Wang; David T Wong Journal: Clin Chem Date: 2006-12 Impact factor: 8.327
Authors: Shen Hu; Yongming Xie; Prasanna Ramachandran; Rachel R Ogorzalek Loo; Yang Li; Joseph A Loo; David T Wong Journal: Proteomics Date: 2005-04 Impact factor: 3.984
Authors: Shen Hu; Patricia Denny; Paul Denny; Yongming Xie; Joseph A Loo; Lawrence E Wolinsky; Yang Li; Jim McBride; Rachel R Ogorzalek Loo; Mavash Navazesh; David T Wong Journal: Int J Oncol Date: 2004-11 Impact factor: 5.650
Authors: Yang Li; Maie A R St John; Xiaofeng Zhou; Yong Kim; Uttam Sinha; Richard C K Jordan; David Eisele; Elliot Abemayor; David Elashoff; No-Hee Park; David T Wong Journal: Clin Cancer Res Date: 2004-12-15 Impact factor: 12.531
Authors: Maie A R St John; Yang Li; Xiaofeng Zhou; Paul Denny; Chih-Ming Ho; Carlo Montemagno; Wenyuan Shi; Fengxia Qi; Benjamin Wu; Uttam Sinha; Richard Jordan; Lawrence Wolinsky; No-Hee Park; Honghu Liu; Elliot Abemayor; David T W Wong Journal: Arch Otolaryngol Head Neck Surg Date: 2004-08
Authors: Ebbing P de Jong; Susan K van Riper; Joseph S Koopmeiners; John V Carlis; Timothy J Griffin Journal: Clin Chim Acta Date: 2011-08-24 Impact factor: 3.786
Authors: Franky D Shah; Rasheedunnisa Begum; Bhairavi N Vajaria; Kinjal R Patel; Jayendra B Patel; Shilin N Shukla; Prabhudas S Patel Journal: Indian J Clin Biochem Date: 2011-08-09
Authors: Samantha H Chiang; Gerald A Thomas; Wei Liao; Tristan Grogan; Robert L Buck; Laurel Fuentes; Maha Yakob; Mary J Laughlin; Chris Schafer; Abu Nazmul-Hossain; Fang Wei; David Elashoff; Paul D Slowey; David T W Wong Journal: Biotechniques Date: 2015-02-01 Impact factor: 1.993
Authors: Jovanka Gasic; Ljiljana Kesic; Jelena Popovic; Aleksandar Mitić; Marija Nikolic; Sasa Stankovic; Radomir Barac Journal: Med Sci Monit Date: 2012-03